What's in Intra-Cellular Therapies, Inc.'s pipeline?

Intra-Cellular Therapies, Inc. has 11 drugs in our index: 0 marketed, 0 filed, 4 in Phase 3, 1 in Phase 2, 6 in Phase 1.

Which companies overlap with Intra-Cellular Therapies, Inc.'s portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/intra-cellular-therapies-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Intra-Cellular Therapies, Inc. — Portfolio Competitive Intelligence Brief

Intra-Cellular Therapies, Inc. pipeline: 0 marketed, 0 filed, 4 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 4 Phase 3 1 Phase 2 6 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Lumateperone high dose	Lumateperone high dose	phase 3	5-HT7 receptor antagonist / PDE10 inhibitor	5-HT7 receptor, PDE10	Psychiatry / Neurology
Lumateperone low dose	Lumateperone low dose	phase 3	Serotonin-dopamine antagonist	5-HT2A receptor, D2 receptor	Psychiatry
ITI-007 (Lumateperone)	ITI-007 (Lumateperone)	phase 3	Serotonin 5-HT7 receptor antagonist / Phosphodiesterase 1 inhibitor	5-HT7 receptor, PDE1	Psychiatry / Neurology
Lumateperone (ITI-007)	Lumateperone (ITI-007)	phase 3	Serotonin-dopamine antagonist	5-HT2A receptor, D2 receptor	Psychiatry

Therapeutic area mix

Psychiatry · 2
Psychiatry / Neurology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for Intra-Cellular Therapies, Inc.:

Cite this brief

Drug Landscape (2026). Intra-Cellular Therapies, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/intra-cellular-therapies-inc. Accessed 2026-05-16.